Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine and DMN Connectivity in ADHD
NCT03661788Phase 4Completed
- Sponsor
- RWTH Aachen University
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by RWTH Aachen University. Started May 2016; status: completed.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03661788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03661788.